Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Corrigendum to "Bispecific antibodies" Drug Discov. Today 20 (July (7)) (2015) 838-847, and . Drug Discovery Today, 24 (7): 1422 (2019)Correction to: https://doi.org/10.1016/j.drudis.2015.02.008.Fc-based Duokines : dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc), , , , , , and . OncoImmunology, 11 (1): 2028961 (2022)Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity, , , , , , , , , and 1 other author(s). International journal of cancer, 136 (9): 2228-2240 (2015)Bispecific antibodies, and . Science, 372 (6545): 916-917 (2021)GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments, and . Molecules, 27 (10): 3272 (2022)Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes., , , and . Methods in molecular biology (Clifton, N.J.), (2010)The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity, , , , , , and . Protein Engineering, Design and Selection, 25 (10): 603--612 (October 2012)Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma, , , , , , , , , and 1 other author(s). npj Systems Biology and Applications, 4 (1): 39 (December 2018)A novel expression and purification system for the production of enzymatic and biologically active human granzyme B, , , , , , , and . Journal of Immunological Methods, 371 (1-2): 8--17 (2011)Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells, , , and . Journal of Drug Targeting, 15 (6): 399--406 (2007)